|
2024
|
Invention
|
Crystal form of compound and use thereof. The present application provides crystal forms A and B ... |
|
|
Invention
|
Salts of compounds, crystal forms thereof, preparation method therefor and use thereof. Provided ... |
|
2023
|
Invention
|
Use of compound in preparation of drug for treatment or prevention of mycobacterium tuberculosis ... |
|
|
Invention
|
Pharmaceutical composition comprising sulbactam and avibactam, and application thereof.
The pres... |
|
|
Invention
|
Rifamycin-quinolizinone coupled molecule ointment and method for preparing same. Provided is a ri... |
|
|
Invention
|
H. pylori infection. H. pylori) infection in a patient in need thereof. |
|
|
Invention
|
Method and use of compound for treating diseases. Provided in the present application is a method... |
|
|
Invention
|
Method of treating disease using compound, and use of compound. Provided in the present applicati... |
|
|
Invention
|
Joint cavity drug administration method, and use thereof. The present application provides a meth... |
|
|
Invention
|
Method for treating prosthetic joint infection by using compound. Provided in the present applica... |
|
|
Invention
|
Method for preventing prosthetic joint infection by using compound. The present application provi... |
|
2022
|
Invention
|
Pharmaceutical composition comprising sulbactam and avibactam, and application thereof. The prese... |
|
|
Invention
|
Methods for preventing or treating h. pylori infection. The present disclosure provides methods, ... |
|
2020
|
Invention
|
Penam derivatives for treating bacterial infections. Novel iron chelating group conjugated penam ... |
|
2019
|
Invention
|
Use of rifamycin-nitroimidazole coupling molecule.
The present invention provides a use of a rif... |
|
|
Invention
|
Use of rifamycin-quinolizidone coupling molecule.
The present invention provides a use of a rifa... |
|
2018
|
Invention
|
Antibacterial pharmaceutical combination and method for treating gram-negative bacteria infection... |
|
2017
|
Invention
|
Anti-microbial composition for treating gram-negative bacterial infection. The present invention ... |
|
2009
|
Invention
|
Bicyclic nitroimidazole-substituted phenyl oxazolidinones. Mycobacterium tuberculosis. |
|
|
Invention
|
Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones. The current inve... |
|
2008
|
Invention
|
Quinolone carboxylic acid-substituted rifamycin derivatives. The compounds include substituted ri... |
|
2007
|
Invention
|
Nitroheteroaryl-containing rifamycin derivatives. Substituted rifamycin derivatives in which a ni... |
|
2005
|
Invention
|
(r/s) rifamycin derivatives, their preparation and pharmaceutical compositions. Rifamycin derivat... |
|
|
Invention
|
Rifamycin derivatives. 4) forms):
wherein: a preferred R comprises hydrogen, acetyl; L is a lin... |
|
|
Invention
|
(r/s) rifamycin derivatives, their preparations and pharmaceutical compositions. 4) forms):
2 co... |
|
|
Invention
|
Spiro-rifamycin derivatives targeting rna polymerase. Compounds of the current invention relate t... |
|
|
Invention
|
C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes. Compounds of ... |
|
|
Invention
|
Rifamycin derivatives effective against drug-resistant microbes. Rifamycin derivatives having ant... |
|
|
Invention
|
Rifamycin imino derivatives effective against drug-resistant microbes. The present invention rela... |
